Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Arrhythmias

  Free Subscription


Articles published in Stroke

Retrieve available abstracts of 135 articles:
HTML format



Single Articles


    May 2020
  1. KRITTAYAPHONG R, Winijkul A, Kunjara-Na-Ayudhya R, Apiyasawat S, et al
    Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population: The COOL-AF Registry.
    Stroke. 2020 May 11:STROKEAHA120029295. doi: 10.1161/STROKEAHA.120.029295.
    PubMed     Abstract available


  2. BODIN A, Bisson A, Gaborit C, Herbert J, et al
    Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions.
    Stroke. 2020 May 11:STROKEAHA120029048. doi: 10.1161/STROKEAHA.120.029048.
    PubMed     Abstract available



  3. Correction to: Ischemic Stroke and Bleeding: Clinical Benefit of Anticoagulation in Atrial Fibrillation After Intracerebral Hemorrhage.
    Stroke. 2020;51:e100.
    PubMed    



  4. Correction to: Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke.
    Stroke. 2020;51:e99.
    PubMed    


    April 2020
  5. LEE SR, Choi EK, Lip GYH
    Response by Lee et al to Letter Regarding Article, "Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage".
    Stroke. 2020 Apr 27:STROKEAHA120029551. doi: 10.1161/STROKEAHA.120.029551.
    PubMed    


  6. LIANG B, Zhao YX, Gu N
    Letter by Liang et al Regarding Article, "Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage".
    Stroke. 2020 Apr 27:STROKEAHA120029434. doi: 10.1161/STROKEAHA.120.029434.
    PubMed    


  7. KOKKINIDIS DG, Zareifopoulos N, Theochari CA, Arfaras-Melainis A, et al
    Association Between Atrial Fibrillation and Cognitive Impairment in Individuals With Prior Stroke: A Meta-Analysis and Meta-Regression Analysis.
    Stroke. 2020 Apr 21:STROKEAHA119027815. doi: 10.1161/STROKEAHA.119.027815.
    PubMed     Abstract available


  8. KHURSHID S, Trinquart L, Weng LC, Hulme OL, et al
    Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke.
    Stroke. 2020 Apr 7:STROKEAHA120028837. doi: 10.1161/STROKEAHA.120.028837.
    PubMed     Abstract available



  9. Correction to: Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study.
    Stroke. 2020;51:e71.
    PubMed    


    February 2020
  10. TANAKA K, Koga M, Lee KJ, Kim BJ, et al
    Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke.
    Stroke. 2020 Feb 26:STROKEAHA119027275. doi: 10.1161/STROKEAHA.119.027275.
    PubMed     Abstract available


    January 2020
  11. STANTON RJ, Eckman MH, Woo D, Moomaw CJ, et al
    Ischemic Stroke and Bleeding: Clinical Benefit of Anticoagulation in Atrial Fibrillation After Intracerebral Hemorrhage.
    Stroke. 2020 Jan 31:STROKEAHA119027370. doi: 10.1161/STROKEAHA.119.027370.
    PubMed     Abstract available


  12. YE K, Chen W
    Letter by Ye and Chen Regarding Article, "Metabolic Syndrome and Risk of Ischemic Stroke in Atrial Fibrillation: ARIC Study".
    Stroke. 2020 Jan 29:STROKEAHA119028635. doi: 10.1161/STROKEAHA.119.028635.
    PubMed    


  13. MIZOGUCHI T, Tanaka K, Toyoda K, Yoshimura S, et al
    Early Initiation of Direct Oral Anticoagulants After Onset of Stroke and Short- and Long-Term Outcomes of Patients With Nonvalvular Atrial Fibrillation.
    Stroke. 2020 Jan 22:STROKEAHA119028118. doi: 10.1161/STROKEAHA.119.028118.
    PubMed     Abstract available



  14. Correction to: Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study.
    Stroke. 2020 Jan 10:STR0000000000000218. doi: 10.1161/STR.0000000000000218.
    PubMed    


  15. GOMIS M, Davalos A, Purroy F, Cardona P, et al
    Stroke Risk Analysis, a System With a High Detection Rate of Atrial Fibrillation in Stroke and Transient Ischemic Attack.
    Stroke. 2020;51:262-267.
    PubMed     Abstract available


  16. OLIVIERI O, Cappellari M, Turcato G, Bonetti B, et al
    Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII.
    Stroke. 2020;51:61-68.
    PubMed     Abstract available


  17. MURTHY SB, Diaz I, Wu X, Merkler AE, et al
    Risk of Arterial Ischemic Events After Intracerebral Hemorrhage.
    Stroke. 2020;51:137-142.
    PubMed     Abstract available


  18. GUTIERREZ J, Gil-Guevara A, Ramaswamy S, DeRosa J, et al
    Classification of Covert Brain Infarct Subtype and Risk of Death and Vascular Events.
    Stroke. 2020;51:90-98.
    PubMed     Abstract available


    December 2019
  19. ALBERTS M, Chen YW, Lin JH, Kogan E, et al
    Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin.
    Stroke. 2019 Dec 31:STROKEAHA119025554. doi: 10.1161/STROKEAHA.119.025554.
    PubMed     Abstract available


  20. NTAIOS G, Perlepe K, Lambrou D, Sirimarco G, et al
    External Performance of the HAVOC Score for the Prediction of New Incident Atrial Fibrillation.
    Stroke. 2019 Dec 12:STROKEAHA119027990. doi: 10.1161/STROKEAHA.119.027990.
    PubMed     Abstract available


  21. LEE SR, Choi EK, Kwon S, Jung JH, et al
    Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage.
    Stroke. 2019 Dec 9:STROKEAHA119028030. doi: 10.1161/STROKEAHA.119.028030.
    PubMed     Abstract available


  22. WASSER K, Weber-Kruger M, Groschel S, Uphaus T, et al
    Brain Natriuretic Peptide and Discovery of Atrial Fibrillation After Stroke: A Subanalysis of the Find-AFRANDOMISED Trial.
    Stroke. 2019 Dec 9:STROKEAHA119026496. doi: 10.1161/STROKEAHA.119.026496.
    PubMed     Abstract available


  23. CHENG WH, Chao TF
    Response by Cheng and Chao to Letter Regarding Article, "Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation".
    Stroke. 2019 Dec 4:STROKEAHA119027909. doi: 10.1161/STROKEAHA.119.027909.
    PubMed    


  24. LEE KJ, Kim BJ, Han MK, Kim JT, et al
    Effect of Heart Rate on Stroke Recurrence and Mortality in Acute Ischemic Stroke With Atrial Fibrillation.
    Stroke. 2019 Dec 4:STROKEAHA119026847. doi: 10.1161/STROKEAHA.119.026847.
    PubMed     Abstract available


  25. XIANG Q, Cui Y
    Letter by Xiang and Cui Regarding Article, "Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation".
    Stroke. 2019 Dec 4:STROKEAHA119027857. doi: 10.1161/STROKEAHA.119.027857.
    PubMed    



  26. Correction to: Atrial Fibrillation Ablation and Reduction of Stroke Events: Understanding the Paradoxical Lack of Evidence.
    Stroke. 2019;50:e438.
    PubMed    


    October 2019
  27. DECKER JJ, Norby FL, Rooney MR, Soliman EZ, et al
    Metabolic Syndrome and Risk of Ischemic Stroke in Atrial Fibrillation: ARIC Study.
    Stroke. 2019 Oct 18:STROKEAHA119025376. doi: 10.1161/STROKEAHA.119.025376.
    PubMed     Abstract available


    September 2019
  28. HO JSY, Tan BYQ, Sia CH
    Letter by Ho et al Regarding Article, "Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source".
    Stroke. 2019 Sep 20:STROKEAHA119027179. doi: 10.1161/STROKEAHA.119.027179.
    PubMed    


  29. JORDAN K, Yaghi S, Song C
    Response by Jordan et al to Letter Regarding Article, "Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source".
    Stroke. 2019 Sep 20:STROKEAHA119027235. doi: 10.1161/STROKEAHA.119.027235.
    PubMed    


  30. LERARIO MP, Grotta JC, Merkler AE, Omran SS, et al
    Association Between Intravenous Thrombolysis and Anaphylaxis Among Medicare Beneficiaries With Acute Ischemic Stroke.
    Stroke. 2019 Sep 13:STROKEAHA119026861. doi: 10.1161/STROKEAHA.119.026861.
    PubMed     Abstract available


  31. BARRA S, Narayanan K, Boveda S, Primo J, et al
    Atrial Fibrillation Ablation and Reduction of Stroke Events: Understanding the Paradoxical Lack of Evidence.
    Stroke. 2019 Sep 12:STROKEAHA119026890. doi: 10.1161/STROKEAHA.119.026890.
    PubMed    


  32. MANWANI B, McCullough LD
    On the Basis of Sex.
    Stroke. 2019;50:2285-2287.
    PubMed    


    August 2019
  33. XUE Z, Zhang H
    Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Asians With Atrial Fibrillation.
    Stroke. 2019 Aug 19:STROKEAHA119026054. doi: 10.1161/STROKEAHA.119.026054.
    PubMed     Abstract available


  34. JORDAN K, Yaghi S, Song C
    Response by Jordan et al to Letter Regarding Article, "Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source".
    Stroke. 2019 Aug 14:STROKEAHA119026858. doi: 10.1161/STROKEAHA.119.026858.
    PubMed    


  35. MULLER P, Akoum N, Eckardt L
    Letter by Muller et al Regarding Article, "Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source".
    Stroke. 2019 Aug 14:STROKEAHA119026818. doi: 10.1161/STROKEAHA.119.026818.
    PubMed    


  36. BLIN P, Fauchier L, Dureau-Pournin C, Sacher F, et al
    Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation.
    Stroke. 2019 Aug 8:STROKEAHA119025824. doi: 10.1161/STROKEAHA.119.025824.
    PubMed     Abstract available


    July 2019
  37. LEE HJ, Kim HK, Jung JH, Han KD, et al
    Novel Oral Anticoagulants for Primary Stroke Prevention in Hypertrophic Cardiomyopathy Patients With Atrial Fibrillation.
    Stroke. 2019 Jul 25:STROKEAHA119026048. doi: 10.1161/STROKEAHA.119.026048.
    PubMed     Abstract available


  38. ZHU X, Cao S, Ding C
    Letter by Zhu et al Regarding Article, "Atrial Fibrillation Known Before or Detected After Stroke Share Similar Risk of Ischemic Stroke Recurrence and Death".
    Stroke. 2019 Jul 25:STROKEAHA119026368. doi: 10.1161/STROKEAHA.119.026368.
    PubMed    


  39. YANG XM, Li ZX, Wang YJ
    Response by Yang et al to Letter Regarding Article, "Atrial Fibrillation Known Before or Detected After Stroke Share Similar Risk of Ischemic Stroke Recurrence and Death".
    Stroke. 2019 Jul 25:STROKEAHA119026551. doi: 10.1161/STROKEAHA.119.026551.
    PubMed    


  40. MCALISTER FA, Yan L, Roos LL, Lix LM, et al
    Parental Atrial Fibrillation and Stroke or Atrial Fibrillation in Young Adults.
    Stroke. 2019 Jul 24:STROKEAHA119025124. doi: 10.1161/STROKEAHA.119.025124.
    PubMed     Abstract available


  41. KNIJNIK L, Rivera M, Blumer V, Cardoso R, et al
    Prevention of Stroke in Atrial Fibrillation After Coronary Stenting.
    Stroke. 2019 Jul 15:STROKEAHA119026078. doi: 10.1161/STROKEAHA.119.026078.
    PubMed     Abstract available


  42. CHENG WH, Chao TF, Lin YJ, Chang SL, et al
    Low-Dose Rivaroxaban and Risks of Adverse Events in Patients With Atrial Fibrillation.
    Stroke. 2019 Jul 10:STROKEAHA119025623. doi: 10.1161/STROKEAHA.119.025623.
    PubMed     Abstract available


    June 2019
  43. PACIARONI M, Agnelli G, Caso V, Silvestrelli G, et al
    Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.
    Stroke. 2019 Jun 25:STROKEAHA119025350. doi: 10.1161/STROKEAHA.119.025350.
    PubMed     Abstract available


  44. ALTAVILLA R, Caso V, Bandini F, Agnelli G, et al
    Anticoagulation After Stroke in Patients With Atrial Fibrillation.
    Stroke. 2019 Jun 21:STROKEAHA118022856. doi: 10.1161/STROKEAHA.118.022856.
    PubMed     Abstract available


  45. CAMPBELL BCV
    More Reasons to Avoid Bridging Anticoagulation After Stroke in Patients With Atrial Fibrillation.
    Stroke. 2019 Jun 21:STROKEAHA119025770. doi: 10.1161/STROKEAHA.119.025770.
    PubMed    


  46. KNEIHSL M, Gattringer T, Bisping E, Scherr D, et al
    Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation-Related Stroke.
    Stroke. 2019 Jun 20:STROKEAHA119025339. doi: 10.1161/STROKEAHA.119.025339.
    PubMed     Abstract available


  47. KOZIEL M, Potpara TS, Lip GYH
    Using Blood Biomarkers to Identify Atrial Fibrillation-Related Stroke.
    Stroke. 2019 Jun 20:STROKEAHA119026185. doi: 10.1161/STROKEAHA.119.026185.
    PubMed    


  48. TSIVGOULIS G, Katsanos AH, Grory BM, Kohrmann M, et al
    Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia.
    Stroke. 2019 Jun 20:STROKEAHA119025169. doi: 10.1161/STROKEAHA.119.025169.
    PubMed     Abstract available


  49. LEE SR, Choi EK, Kwon S, Han KD, et al
    Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.
    Stroke. 2019 Jun 18:STROKEAHA119025536. doi: 10.1161/STROKEAHA.119.025536.
    PubMed     Abstract available


  50. JORDAN K, Yaghi S, Poppas A, Chang AD, et al
    Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source.
    Stroke. 2019 Jun 13:STROKEAHA119025384. doi: 10.1161/STROKEAHA.119.025384.
    PubMed     Abstract available


  51. BROWN DL, Xu G, Belinky Krzyske AM, Buhay NC, et al
    Electrocardiomatrix Facilitates Accurate Detection of Atrial Fibrillation in Stroke Patients.
    Stroke. 2019 Jun 10:STROKEAHA119025361. doi: 10.1161/STROKEAHA.119.025361.
    PubMed     Abstract available


  52. PANA TA, McLernon DJ, Mamas MA, Bettencourt-Silva JH, et al
    Individual and Combined Impact of Heart Failure and Atrial Fibrillation on Ischemic Stroke Outcomes.
    Stroke. 2019 Jun 3:STROKEAHA119025481. doi: 10.1161/STROKEAHA.119.025481.
    PubMed     Abstract available


  53. LEE SR, Choi EK, Han KD, Jung JH, et al
    Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function.
    Stroke. 2019;50:1480-1489.
    PubMed     Abstract available


    May 2019
  54. JAYARAMAN DK, Alcusky M, Moonis M
    Letter by Jayaraman et al Regarding Articles, "Higher Incidence of Ischemic Stroke in Patients Taking Novel Oral Anticoagulants" and "Effectiveness and Safety of Oral Anticoagulants among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Stud
    Stroke. 2019 May 16:STROKEAHA119024817. doi: 10.1161/STROKEAHA.119.024817.
    PubMed    


  55. RIVERA-CARAVACA JM, Marin F, Vilchez JA, Galvez J, et al
    Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores.
    Stroke. 2019 May 14:STROKEAHA118024305. doi: 10.1161/STROKEAHA.118.024305.
    PubMed     Abstract available


  56. SUR NB, Wang K, Di Tullio MR, Gutierrez CM, et al
    Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation.
    Stroke. 2019 May 14:STROKEAHA118023959. doi: 10.1161/STROKEAHA.118.023959.
    PubMed     Abstract available


  57. LIN MH, Kamel H, Singer DE, Wu YL, et al
    Perioperative/Postoperative Atrial Fibrillation and Risk of Subsequent Stroke and/or Mortality.
    Stroke. 2019 May 2:STROKEAHA118023921. doi: 10.1161/STROKEAHA.118.023921.
    PubMed     Abstract available


  58. YANG XM, Rao ZZ, Gu HQ, Zhao XQ, et al
    Atrial Fibrillation Known Before or Detected After Stroke Share Similar Risk of Ischemic Stroke Recurrence and Death.
    Stroke. 2019;50:1124-1129.
    PubMed     Abstract available


    April 2019
  59. BERMAN JP, Norby FL, Mosley T, Soliman EZ, et al
    Atrial Fibrillation and Brain Magnetic Resonance Imaging Abnormalities.
    Stroke. 2019;50:783-788.
    PubMed     Abstract available


  60. MACHA K, Marsch A, Siedler G, Breuer L, et al
    Cerebral Ischemia in Patients on Direct Oral Anticoagulants.
    Stroke. 2019;50:873-879.
    PubMed     Abstract available


    March 2019
  61. LEE SR, Choi EK, Han KD, Jung JH, et al
    Optimal Rivaroxaban Dose in Asian Patients With Atrial Fibrillation and Normal or Mildly Impaired Renal Function.
    Stroke. 2019 Mar 27:STROKEAHA118024210. doi: 10.1161/STROKEAHA.118.024210.
    PubMed     Abstract available


  62. SHAO IY, Power MC, Mosley T, Jack C Jr, et al
    Association of Atrial Fibrillation With White Matter Disease.
    Stroke. 2019 Mar 18:STROKEAHA118023386. doi: 10.1161/STROKEAHA.118.023386.
    PubMed     Abstract available


  63. NIELSEN PB, Skjoth F, Sogaard M, Kjaeldgaard JN, et al
    Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage.
    Stroke. 2019 Mar 14:STROKEAHA118023797. doi: 10.1161/STROKEAHA.118.023797.
    PubMed     Abstract available


    February 2019
  64. DI CASTELNUOVO A, Veronesi G, Costanzo S, Zeller T, et al
    NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke.
    Stroke. 2019 Feb 21:STROKEAHA118023218. doi: 10.1161/STROKEAHA.118.023218.
    PubMed     Abstract available


    December 2018
  65. CHO MS, Yun JE, Park JJ, Kim YJ, et al
    Outcomes After Use of Standard- and Low-Dose Non-Vitamin K Oral Anticoagulants in Asian Patients With Atrial Fibrillation.
    Stroke. 2018 Dec 3:STROKEAHA118023093. doi: 10.1161/STROKEAHA.118.023093.
    PubMed     Abstract available


  66. RUIZ VARGAS E, Sposato LA, Lee SAW, Hachinski V, et al
    Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease.
    Stroke. 2018;49:2844-2850.
    PubMed     Abstract available


  67. LIP GYH, Keshishian A, Li X, Hamilton M, et al
    Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients.
    Stroke. 2018;49:2933-2944.
    PubMed     Abstract available


  68. SHPAK M, Ramakrishnan A, Nadasdy Z, Cowperthwaite M, et al
    Higher Incidence of Ischemic Stroke in Patients Taking Novel Oral Anticoagulants.
    Stroke. 2018;49:2851-2856.
    PubMed     Abstract available


  69. PERSSON CU, Svardsudd K, Rusek L, Blomstrand C, et al
    Determinants of Stroke in a General Male Population.
    Stroke. 2018;49:2830-2836.
    PubMed     Abstract available


    November 2018
  70. YIIN GSC, Li L, Bejot Y, Rothwell PM, et al
    Time Trends in Atrial Fibrillation-Associated Stroke and Premorbid Anticoagulation.
    Stroke. 2018 Nov 29:STROKEAHA118022249. doi: 10.1161/STROKEAHA.118.022249.
    PubMed     Abstract available


  71. CHEN LY, Norby FL, Chamberlain AM, MacLehose RF, et al
    CHA2DS2-VASc Score and Stroke Prediction in Atrial Fibrillation in Whites, Blacks, and Hispanics.
    Stroke. 2018 Nov 29:STROKEAHA118021453. doi: 10.1161/STROKEAHA.118.021453.
    PubMed     Abstract available


  72. JANION-SADOWSKA A, Chrapek M, Konieczynska M, Undas A, et al
    Altered Fibrin Clot Properties Predict Stroke and Bleedings in Patients With Atrial Fibrillation on Rivaroxaban.
    Stroke. 2018 Nov 21:STROKEAHA118023712. doi: 10.1161/STROKEAHA.118.023712.
    PubMed     Abstract available


  73. MURPHY MP, Kuramatsu JB, Leasure A, Falcone GJ, et al
    Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage.
    Stroke. 2018;49:2652-2658.
    PubMed     Abstract available


  74. YAGHI S, Chang AD, Cutting S, Jayaraman M, et al
    Troponin Improves the Yield of Transthoracic Echocardiography in Ischemic Stroke Patients of Determined Stroke Subtype.
    Stroke. 2018;49:2777-2779.
    PubMed     Abstract available


    October 2018
  75. WITSCH J, Merkler AE, Chen ML, Navi BB, et al
    Incidence of Atrial Fibrillation in Patients With Recent Ischemic Stroke Versus Matched Controls.
    Stroke. 2018;49:2529-2531.
    PubMed     Abstract available


  76. OGAWA H, An Y, Ikeda S, Aono Y, et al
    Progression From Paroxysmal to Sustained Atrial Fibrillation Is Associated With Increased Adverse Events.
    Stroke. 2018;49:2301-2308.
    PubMed     Abstract available


  77. YU HT, Yang PS, Kim TH, Jang E, et al
    Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial Fibrillation.
    Stroke. 2018;49:2421-2429.
    PubMed     Abstract available


  78. CHAUSSON N, Soumah D, Aghasaryan M, Altarcha T, et al
    Reversal of Vitamin K Antagonist Therapy Before Thrombolysis for Acute Ischemic Stroke.
    Stroke. 2018;49:2526-2528.
    PubMed     Abstract available


    September 2018
  79. FORSLUND T, Komen JJ, Andersen M, Wettermark B, et al
    Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants.
    Stroke. 2018;49:2122-2128.
    PubMed     Abstract available


    July 2018
  80. KIM TH, Yang PS, Yu HT, Jang E, et al
    Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation: Cohort Data Covering the Entire Korean Population.
    Stroke. 2018 Jul 16. pii: STROKEAHA.118.021047.
    PubMed     Abstract available


  81. FROST L, Johnsen SP
    Age and Risk of Stroke in Asians With Atrial Fibrillation: The Clock Is Ticking.
    Stroke. 2018 Jul 16. pii: STROKEAHA.118.022038.
    PubMed    


  82. LAMSAM L, Sussman ES, Iyer AK, Bhambhvani HP, et al
    Intracranial Hemorrhage in Deep Vein Thrombosis/Pulmonary Embolus Patients Without Atrial Fibrillation: Direct Oral Anticoagulants Versus Warfarin.
    Stroke. 2018 Jul 10. pii: STROKEAHA.118.022156.
    PubMed     Abstract available


    June 2018
  83. HAMATANI Y, Nagai T, Nakai M, Nishimura K, et al
    Elevated Plasma D-Dimer Level Is Associated With Short-Term Risk of Ischemic Stroke in Patients With Acute Heart Failure.
    Stroke. 2018 Jun 7. pii: STROKEAHA.118.021899. doi: 10.1161/STROKEAHA.118.021899
    PubMed     Abstract available


    May 2018
  84. GUROL ME
    Secondary Stroke Prevention in Atrial Fibrillation: New Insights Into an Old Problem.
    Stroke. 2018 May 8. pii: STROKEAHA.118.021262. doi: 10.1161/STROKEAHA.118.021262
    PubMed    


  85. REDDY VY, Akehurst RL, Amorosi SL, Gavaghan MB, et al
    Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation.
    Stroke. 2018 May 8. pii: STROKEAHA.117.018825. doi: 10.1161/STROKEAHA.117.018825
    PubMed     Abstract available


    April 2018
  86. KURMANN R, Engelter ST, Michel P, Luft AR, et al
    Impact of Smoking on Clinical Outcome and Recanalization After Intravenous Thrombolysis for Stroke: Multicenter Cohort Study.
    Stroke. 2018 Apr 10. pii: STROKEAHA.117.017976.
    PubMed     Abstract available


    March 2018
  87. KAMEL H, Bartz TM, Elkind MSV, Okin PM, et al
    Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).
    Stroke. 2018 Mar 13. pii: STROKEAHA.117.020059.
    PubMed     Abstract available


  88. YOUSUFUDDIN M, Young N, Keenan L, Olson T, et al
    Five-Year Mortality After Transient Ischemic Attack: Focus on Cardiometabolic Comorbidity and Hospital Readmission.
    Stroke. 2018;49:730-733.
    PubMed     Abstract available


    January 2018
  89. LINDLEY RI
    Stroke Prevention in the Very Elderly.
    Stroke. 2018 Jan 25. pii: STROKEAHA.117.017952.
    PubMed    


  90. FISHER M, Hill JA
    Ischemic Stroke Mandates Cross-Disciplinary Collaboration.
    Stroke. 2018 Jan 8. pii: STROKEAHA.117.020014. doi: 10.1161/STROKEAHA.117.020014
    PubMed    


    December 2017
  91. GUROL ME
    Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk.
    Stroke. 2017 Dec 4. pii: STROKEAHA.117.017081. doi: 10.1161/STROKEAHA.117.017081
    PubMed    



  92. Correction to: Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.
    Stroke. 2017;48:e368.
    PubMed    


    November 2017
  93. PROIETTI M, Romanazzi I, Romiti GF, Farcomeni A, et al
    Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Stroke. 2017 Nov 22. pii: STROKEAHA.117.018395.
    PubMed     Abstract available


  94. YAMADA S, Lin CY, Chang SL, Chao TF, et al
    Risk of Stroke in Patients With Short-Run Atrial Tachyarrhythmia.
    Stroke. 2017 Nov 16. pii: STROKEAHA.117.018475.
    PubMed     Abstract available


  95. ETHERTON MR, Wu O, Cougo P, Giese AK, et al
    Structural Integrity of Normal Appearing White Matter and Sex-Specific Outcomes After Acute Ischemic Stroke.
    Stroke. 2017 Nov 10. pii: STROKEAHA.117.019258.
    PubMed     Abstract available


  96. SHOAMANESH A, Charidimou A, Sharma M, Hart RG, et al
    Should Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds be Anticoagulated?
    Stroke. 2017 Nov 7. pii: STROKEAHA.117.018467. doi: 10.1161/STROKEAHA.117.018467
    PubMed    


    October 2017
  97. VINEREANU D, Lopes RD, Mulder H, Gersh BJ, et al
    Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin.
    Stroke. 2017 Oct 31. pii: STROKEAHA.117.017574.
    PubMed     Abstract available


  98. CHATURVEDI S, Molina CA, Selim MH, Diener HC, et al
    Off-Label Use of Direct Oral Anticoagulants in Intracerebral Hemorrhage Patients With Prosthetic Valves.
    Stroke. 2017 Oct 13. pii: STROKEAHA.117.017592.
    PubMed    


  99. CHA MJ, Choi EK, Han KD, Lee SR, et al
    Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Atrial Fibrillation.
    Stroke. 2017 Oct 3. pii: STROKEAHA.117.018773. doi: 10.1161/STROKEAHA.117.018773
    PubMed     Abstract available


    September 2017
  100. KIM TH, Yang PS, Kim D, Yu HT, et al
    CHA2DS2-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study.
    Stroke. 2017 Sep 22. pii: STROKEAHA.117.018551.
    PubMed     Abstract available


  101. HILKENS NA, Algra A, Greving JP
    Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.
    Stroke. 2017 Sep 20. pii: STROKEAHA.117.019183.
    PubMed     Abstract available


  102. SELIM M, Diener HC
    Atrial Fibrillation and Microbleeds.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017085.
    PubMed    


  103. GOLDSTEIN LB
    Anticoagulation in Patients With Atrial Fibrillation in the Setting of Prior Hemorrhage: An Ongoing Dilemma.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017082.
    PubMed    


  104. THIJS V
    Atrial Fibrillation Detection: Fishing for An Irregular Heartbeat Before and After Stroke.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017083.
    PubMed    


  105. YAGHI S, Kamel H
    Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.017084.
    PubMed    


  106. FISHER M
    Introducing Focused Updates in Cerebrovascular Disease.
    Stroke. 2017 Sep 15. pii: STROKEAHA.117.019122.
    PubMed    


  107. DRABIK L, Wolkow P, Undas A
    Fibrin Clot Permeability as a Predictor of Stroke and Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    Stroke. 2017 Sep 13. pii: STROKEAHA.117.018143.
    PubMed     Abstract available


  108. BISSON A, Clementy N, Bodin A, Angoulvant D, et al
    Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke.
    Stroke. 2017 Sep 1. pii: STROKEAHA.117.018251. doi: 10.1161/STROKEAHA.117.018251
    PubMed     Abstract available


    August 2017
  109. YOON CY, Noh J, Jhee JH, Chang TI, et al
    Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Nationwide Population-Based Study.
    Stroke. 2017 Aug 11. pii: STROKEAHA.117.017114.
    PubMed     Abstract available


  110. THOREN M, Azevedo E, Dawson J, Egido JA, et al
    Predictors for Cerebral Edema in Acute Ischemic Stroke Treated With Intravenous Thrombolysis.
    Stroke. 2017 Aug 3. pii: STROKEAHA.117.018223. doi: 10.1161/STROKEAHA.117.018223
    PubMed     Abstract available



  111. Correction to: Ischemic Stroke in Nonvalvular Atrial Fibrillation at Warfarin Initiation: Assessment via a Large Insurance Database.
    Stroke. 2017;48:e239.
    PubMed    


    July 2017
  112. NTAIOS G, Papavasileiou V, Makaritsis K, Vemmos K, et al
    Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Stroke. 2017 Jul 17. pii: STROKEAHA.117.017549.
    PubMed     Abstract available


  113. MAZUREK M, Shantsila E, Lane DA, Wolff A, et al
    Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry.
    Stroke. 2017 Jul 5. pii: STROKEAHA.116.016146. doi: 10.1161/STROKEAHA.116.016146
    PubMed     Abstract available


    June 2017
  114. HERNANDEZ I, Saba S, Zhang Y
    Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial Fibrillation.
    Stroke. 2017 Jun 27. pii: STROKEAHA.117.017683.
    PubMed     Abstract available


  115. COLEMAN CI, Peacock WF, Bunz TJ, Alberts MJ, et al
    Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Stroke. 2017 Jun 27. pii: STROKEAHA.117.017474.
    PubMed     Abstract available


  116. GOUNIS MJ, Chapot R
    Histological Composition and the Origin of the Thrombus: A New Diagnostic Assay for Secondary Stroke Prevention?
    Stroke. 2017 Jun 16. pii: STROKEAHA.117.017630.
    PubMed    


  117. FLINT AC, Conell C, Ren X, Kamel H, et al
    Statin Adherence Is Associated With Reduced Recurrent Stroke Risk in Patients With or Without Atrial Fibrillation.
    Stroke. 2017 Jun 8. pii: STROKEAHA.117.017343. doi: 10.1161/STROKEAHA.117.017343
    PubMed     Abstract available


    May 2017
  118. APPELROS P, Farahmand B, Terent A, Asberg S, et al
    To Treat or Not to Treat: Anticoagulants as Secondary Preventives to the Oldest Old With Atrial Fibrillation.
    Stroke. 2017 May 9. pii: STROKEAHA.117.016902. doi: 10.1161/STROKEAHA.117.016902
    PubMed     Abstract available


  119. LUBITZ SA, Parsons OE, Anderson CD, Benjamin EJ, et al
    Atrial Fibrillation Genetic Risk and Ischemic Stroke Mechanisms.
    Stroke. 2017 May 3. pii: STROKEAHA.116.016198. doi: 10.1161/STROKEAHA.116.016198
    PubMed     Abstract available


    April 2017
  120. KIM TH, Yang PS, Uhm JS, Kim JY, et al
    CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age >/=75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A K
    Stroke. 2017 Apr 28. pii: STROKEAHA.117.016926.
    PubMed     Abstract available


  121. MACHADO-ALBA JE, Arias-Jaramillo DR, Gaviria-Mendoza A
    Letter by Machado-Alba et al Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".
    Stroke. 2017 Apr 28. pii: STROKEAHA.117.017375.
    PubMed    


  122. BAI Y, Shantsila A, Lip GYH
    Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".
    Stroke. 2017 Apr 28. pii: STROKEAHA.117.017460.
    PubMed    


  123. TEPPER PG, Liu X, Hamilton M, Mardekian J, et al
    Ischemic Stroke in Nonvalvular Atrial Fibrillation at Warfarin Initiation: Assessment via a Large Insurance Database.
    Stroke. 2017 Apr 26. pii: STROKEAHA.116.015535.
    PubMed     Abstract available


  124. LUBITZ SA, Seshadri S, Benjamin EJ
    Response by Lubitz et al to Letter Regarding Article, "Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study".
    Stroke. 2017 Apr 17. pii: STROKEAHA.117.017108.
    PubMed    


  125. SPOSATO LA, Fridman S, Saposnik G
    Letter by Sposato et al Regarding Article, "Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study".
    Stroke. 2017 Apr 17. pii: STROKEAHA.117.017066.
    PubMed    


  126. COLL-VINENT B, Martin A, Sanchez J, Tamargo J, et al
    Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation).
    Stroke. 2017 Apr 7. pii: STROKEAHA.116.014855. doi: 10.1161/STROKEAHA.116.014855
    PubMed     Abstract available


    February 2017
  127. MATTSSON N, Kumarathurai P, Larsen BS, Nielsen OW, et al
    Mild Hypokalemia and Supraventricular Ectopy Increases the Risk of Stroke in Community-Dwelling Subjects.
    Stroke. 2017 Feb 7. pii: STROKEAHA.116.015439. doi: 10.1161/STROKEAHA.116.015439
    PubMed     Abstract available


    January 2017
  128. HOLT TA, Dalton A, Marshall T, Fay M, et al
    Automated Software System to Promote Anticoagulation and Reduce Stroke Risk: Cluster-Randomized Controlled Trial.
    Stroke. 2017 Jan 24. pii: STROKEAHA.116.015468.
    PubMed     Abstract available


    October 2016
  129. WOOD AD, Mannu GS, Clark AB, Tiamkao S, et al
    Rheumatic Mitral Valve Disease Is Associated With Worse Outcomes in Stroke: A Thailand National Database Study.
    Stroke. 2016 Oct 4. pii: STROKEAHA.116.014512.
    PubMed     Abstract available


    July 2016
  130. YONG JH, Thavorn K, Hoch JS, Mamdani M, et al
    Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke.
    Stroke. 2016 Jul 28. pii: STROKEAHA.115.011979.
    PubMed     Abstract available


    June 2016
  131. WINTERHOLLER M, Hollander C, Kerling F, Weber I, et al
    Stroke in Duchenne Muscular Dystrophy: A Retrospective Longitudinal Study in 54 Patients.
    Stroke. 2016 Jun 28. pii: STROKEAHA.116.013678.
    PubMed     Abstract available


  132. STANNE TM, Aberg ND, Nilsson S, Jood K, et al
    Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke.
    Stroke. 2016 Jun 14. pii: STROKEAHA.115.012383.
    PubMed     Abstract available


  133. BERROUSCHOT J, Stoll A, Hogh T, Eschenfelder CC, et al
    Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
    Stroke. 2016 Jun 14. pii: STROKEAHA.116.013550.
    PubMed     Abstract available


  134. PANDEY A, Patel MR, Willis B, Gao A, et al
    Association Between Midlife Cardiorespiratory Fitness and Risk of Stroke: The Cooper Center Longitudinal Study.
    Stroke. 2016 Jun 9. pii: STROKEAHA.115.011532.
    PubMed     Abstract available


    May 2016
  135. GIOIA LC, Kate M, Sivakumar L, Hussain D, et al
    Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation: A Prospective Magnetic Resonance Imaging Study.
    Stroke. 2016 May 24. pii: STROKEAHA.116.013491.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: